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reductase activity alone or in com-
bination with proximal ERp57 mol-
ecules. Notably, under steady-state 
conditions, the total pool of PDI in 
the ER is predominantly oxidized. In 
contrast, the oxidoreductase ERp57 
(at least in the peptide-loading com-
plex) is predominantly in the reduced 
state (Dick et al., 2002). These two 
enzymes may collaborate to reduce 
(ERp57) and oxidize (PDI) MHC 
class I in iterations of peptide bind-
ing events that are part of editing the 
peptide repertoire (Figure 1B).
Intriguingly, unlike ERp57, PDI effi-
ciently binds to peptides (Spee et al., 
1999) and thus may have a dual role 
in MHC class I loading—that is, both 
folding and peptide delivery. Park et 
al. (2006) were unable to separate 
these activities but speculate that this 
could be the case for two reasons. 
First, preventing the binding of pep-
tides to PDI by mutating its peptide-
binding site also prevented correct 
oxidation of MHC class I molecules 
(albeit to a lesser extent). Second, 
blocking peptide transport into the 
ER inhibited MHC class I oxidation. 
Possibly, peptide supply is required 
for PDI-directed MHC class I folding. 
Thus, PDI may set the trap and deliver 
a peptide directly to the waiting jaws 
of the MHC class I peptide-binding 
groove. It is equally possible that pep-
tides are just cofactors for PDI activ-
ity or that the peptide-binding site of 
PDI represents a “foldase” active site. 
This remains to be established.
Finally, Park et al. (2006) provide 
an evolutionary argument for the rel-
evance of PDI activity in the antigen-
presentation pathway. In the “struggle 
for survival,” human cytomegalovirus 
targets various steps in the MHC 
class I antigen-processing pathway 
as a stealth strategy to avoid immune 
detection. In prior work, Park et al. 
(2004) showed that one of these pro-
teins, US3, binds to TAP, MHC class 
I heavy chain, and tapasin, thereby 
inactivating the peptide-editing func-
tion of the latter. They now show that 
US3 also targets PDI for degrada-
tion, thus reducing the capacity of 
infected cells to present antigens. 
PDI degradation also affects other 
folding processes, as “only” 15% of 
available PDI is busy inducing MHC 
class molecules to fold. As Park and 
colleagues elegantly demonstrate, 
viral interest in PDI as a target for 
degradation confirms the importance 
of chaperone proteins for successful 
antigen presentation under normal 
conditions.
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Molecular chaperones are cellular machines that facilitate protein folding. The crystal struc-
tures of HtpG, the Escherichia coli homolog of hsp90, reported in this issue (Shiau et al., 
2006) together with the recently published structures of an hsp90-cochaperone complex 
(Ali et al., 2006) and an hsp90-client protein complex (Vaughan et al., 2006), reveal exciting 
insights into the hsp90 reaction cycle.Cell 127, October 20, 2006 ©2006 Elsevier Inc. 251Molecular chaperones, such as 
eukaryotic heat shock protein 90 
(hsp90), promote the correct folding 
of client proteins. Biochemical stud-
ies have shown that hsp90 is an ATP-
driven machine that cooperates with 
a set of cochaperones (Riggs et al., 
2004). Although the domain architec-ture of hsp90 is conserved between 
E. coli and man, none of the cochap-
erones that aid in hsp90 function in 
the eukaryotic cell have been found in 
prokaryotes. In this issue, Shiau et al. 
(2006) present the crystal structure 
of the archetypal hsp90 chaperone 
in E. coli, HtpG. The new structures reveal the dramatic conformational 
changes in HtpG that accompany its 
ATPase cycle.
The hsp90 protein is modular 
with three well-defined domains, an 
N-terminal ATP binding domain, a 
middle domain that completes the 
ATPase site and binds to client pro-
figure 1. The ATPase cycle of HtpG and Hsp90
Based on the recent structures of apo-HtpG, HtpG-ADP, and yeast hsp90-AMP-PNP, a cycle of 
conformational changes can be reconstituted. The slow steps during the ATPase cycle are the 
conformational changes preceeding ATP hydrolysis. These steps are regulated by Sti1, Cdc37 
(inhibition), and Aha1 (stimulation). In contrast, the cochaperone p23 binds to the ATP-com-
plexed and catalytically active conformation and slows down ATP turnover.teins, and a C-terminal dimerization 
domain. During the ATPase cycle, 
the three domains of hsp90 move 
from an ATP-free “open” state to an 
ATP-bound “closed” state (Figure 1). 
Biochemical experiments suggested 
that a coordinated series of confor-
mational changes occur after bind-
ing of ATP. These include the tran-
sient dimerization of the N-terminal 
domains and the association of the 
N-terminal and the middle domains 
(Richter et al., 2005; Pearl and Pro-
dromou, 2006). Consistent with this 
proposal, the structure of HtpG and 
the recently published structure of 
yeast hsp90, in complex with its 
cochaperone p23, show exactly the 
predicted rearrangements (Shiau et 
al., 2006; Ali et al. 2006). However, 
the extent to which nucleotide bind-
ing modulates the conformation is 252 Cell 127, October 20, 2006 ©2006 Eastonishingly large for HtpG. For 
yeast hsp90, the changes between 
an open and closed conformation 
are more subtle. Thus, although the 
basic conformational transition is 
similar between bacteria and yeast, 
the amplitudes of the changes are 
different.
The open conformation appears to 
be flexible in both E. coli HtpG and in 
yeast hsp90. The new structures sug-
gest that during the ATPase cycle, 
dramatic rearrangements occur, 
which lead to the compaction of 
the molecule. The structure of yeast 
hsp90 shows a closed state, in which 
the N-terminal domains are linked 
via strand exchange. Stabilization of 
the closed state required the partial 
deletion of the linker region between 
the N-terminal and middle domains 
and the presence of two stabilizers: lsevier Inc.a nonhydrolyzable ATP analog (AMP-
PNP) and the cochaperone p23/Sba1. 
Interestingly, this indicates that signif-
icant tension is inherent in the closed 
state. This may be important for the 
subsequent conformational changes 
that complete the chaperone cycle.
Three main structural events can 
be observed when the chaperone 
changes from the open to the closed 
state. Two of these movements 
are around hinge regions, with the 
domains behaving as rigid bodies. 
One hinge is located at the interface of 
the dimerized C-terminal and the mid-
dle domains. This movement radically 
changes the orientation of the two 
subunits, leading to a stronger twist-
ing and a narrowing of the distance 
between the two N-terminal domains. 
The other twist happens at the inter-
face of the N-terminal domain and the 
middle domain. Here, each N-terminal 
domain rotates about 90° to orient to 
the new dimerization interface. Lastly, 
there is a strand exchange between 
the N-terminal domains, which leads 
to the functional assembly of the cat-
alytic site after nucleotide binding.
Surprisingly, the HtpG crystal 
structure and electron micrographs 
show that ADP binding alone causes 
significant conformational changes 
throughout HtpG. This structure may 
represent an intermediate of the 
ATPase cycle in which ATP hydrolysis 
is complete but bound ADP has not 
yet been released. Electron micro-
graphs also imply that a further com-
pact ADP state likely exists in solution, 
which could be part of the cycle. 
Most of the interactions observed 
by crystallography between the N-
terminal domains are due to a novel 
conformation of the so-called “ATP 
lid.” After ATP binding, this loop 
moves over the nucleotide bind-
ing site and induces a sequence of 
conformational changes leading to 
the hydrolysis of ATP (Richter et al., 
2006). The new crystal structures 
illustrate the remarkable flexibility of 
the ATP lid and indicate its possible 
importance for the progression of the 
ATPase cycle.
With the advent of eukaryotes, 
hsp90 apparently developed into 
a complex system regulated by 
Cell 127, October 20, 2006 ©2006 Elsevier Inc. 253cochaperones. The structure of yeast 
hsp90 in a complex with its cochap-
erone p23/Sba1 highlights beautifully 
how the interaction of the cochap-
erone regulates the ATPase cycle of 
hsp90 (Ali et al., 2006). The p23/Sba1 
cochaperone traps hsp90 at a defined 
step in the ATPase cycle where the 
nucleotide is bound, the N-terminal 
domains are connected via strand 
exchange, and the N-terminal domain 
interacts with the middle domain. The 
hsp90 protein is bound by p23/Sba1 
at positions that are only created dur-
ing the process of N-terminal domain 
dimerization. Stabilization of this con-
formation slows the rate of ATP turno-
ver and as a consequence extends 
the half-life of the hsp90-client com-
plex (Johnson and Toft, 1994).
The p23/Sba1 cochaperone is just 
one of a large set of regulatory cochap-
erones. Some of them interact with 
specific regions in hsp90 at important 
points of the ATPase cycle (Figure 1). 
For example, Sti1 specifically inhibits 
the hsp90 ATPase by preventing the 
interaction of the N-terminal domains 
(Richter et al., 2003). These obser-
vations suggest that cochaperones 
might tune the ATPase cycle of hsp90, 
possibly in a client-specific man-
ner. Although none of the cochaper-
ones is essential to drive the cycle in 
yeast, the efficacy of the machinery is 
increased by the possibility of shifting 
into different gears, according to cli-
ent load. For some clients this may be 
of critical importance.
What do the new structures teach us 
about the client binding site in hsp90? 
One would have hoped to recapitulate 
the revelation provided by the first 
crystal structures of the chaperones 
GroEL and hsp70/DnaK. In these 
cases, it was relatively straightfor-
ward to identify the respective client 
binding sites in the crystal structures. 
Not so for hsp90. Neither in the yeast 
hsp90 structure nor in HtpG is there 
an unambiguous binding site. Bio-
chemistry, too, has offered little clar-
ity with reports indicating the binding 
of client proteins to each of the hsp90 
domains.
All major chaperones appear to 
bind their clients mainly via hydro-
phobic binding interfaces. An inter-esting aspect of the hsp90 structures 
is that hydrophobic loops at the inner 
side of the hsp90 dimer are exposed 
in the open states—one each in the 
middle and C-terminal domains. 
They point to the inner sphere of the 
hsp90 dimer and would be favorably 
positioned to transmit nucleotide-
induced conformational changes of 
the hsp90 dimer onto a bound client. 
In HtpG, these loops are subject to 
strong rearrangements after binding 
of ADP. Based on electron micro-
graphs and image processing, even 
further changes are suggested for 
the HtpG-AMP-PNP complex.
The structure of the yeast hsp90-
p23/Sba1 complex confirms the extent 
of these movements. In its “open” 
conformation, the loops occupy con-
formations similar to their homologs 
in HtpG. Addition of AMP-PNP and 
the cochaperone p23/Sba1 dramati-
cally changes the arrangement of the 
subunits. Both of the loops in the mid-
dle and C-terminal domains change 
positions relative to each other. How-
ever, whether they are truly involved in 
client binding remains to be shown.
The first glimpse of hsp90 in a 
complex with a client protein is that 
of hsp90 bound to a kinase together 
with the kinase-specific cochaperone 
Cdc37 (Vaughan et al., 2006). Sur-
prisingly, reconstructions based on 
electron micrographs showed that 
the complexes are asymmetric with 
respect to the binding of the kinase 
and the cochaperone. Within the lim-
its of the resolution of electron micro-
scopy, these data suggest that client 
interactions are formed simultane-
ously by the N-terminal and middle 
domains of one hsp90 monomer. One 
Cdc37 molecule binds to the N-termi-
nal domain of the other hsp90 subunit. 
Interestingly, these interactions seem 
to occur on the outside of the mol-
ecule. Given the wide range of client 
proteins that are unrelated in structure 
and sequence, it is possible that there 
are several ways for them to interact 
with hsp90. This would be facilitated 
by flexible interaction sites on the sur-
face of the hsp90 molecule.
The crystal structures of dis-
tinct conformational states for HtpG 
together with the yeast hsp90-cochaperone structure have pro-
foundly expanded our view of the 
hsp90 chaperone machinery. These 
structures allow us to reinterpret a 
wealth of functional data on hsp90 and 
to develop new concepts concerning 
client activation by hsp90. In this con-
text, the extreme asymmetry of the 
first three-dimensional structure of 
an hsp90-client complex is astonish-
ing. Certainly, further approaches to 
resolve hsp90-client binding and the 
client-activation cycle are required.
It is known that hsp90 binds to a 
variety of target proteins, among them 
many steroid hormone receptors and 
kinases. The number of client proteins 
identified for hsp90 has been growing 
steadily (see http://www.picard.ch/ 
downloads/Hsp90interactors.pdf). 
Because of its many target proteins, 
hsp90 is considered a promising tar-
get for cancer therapy (Whitesell and 
Lindquist, 2005). The recent hsp90 
structures will further stimulate the 
search for novel therapeutic interven-
tions that affect hsp90 function.
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